Atlas Trials

Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo

Clinical trial NCT00570063 · TERMINATED

Trial details

NCT number
NCT00570063
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2007-11-01
Primary completion
2008-02-18
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.